ARCHIVES

L-PAM Benefit To Post-Menopausal Patients Challenged

This article is from The Cancer Letter archive.

Vol. 02 No. 44 | October 29, 1976

Download PDF Visit The Full Archive

Related Articles

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Center Core Grants Picture Less Bleak; Competing Renewals To Receive 50% Of Recommended Increases

January 4, 1980

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

Diabetes Associated With Greater Risk Of Cancer

December 28, 2007

New P01 Guidelines Will Go Into Effect Feb. 1 Not Oct. 1

September 16, 1983